Prions as adaptive conduits of memory and inheritance

Nature Reviews Genetics

Volumn 6, Issue 6, 2005, Pages 435-450

  Shorter, James ^a   Lindquist, Susan ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; GENE PRODUCT; HOMEODOMAIN PROTEIN; MESSENGER RNA; PRION PROTEIN; PROTEIN HET S; PROTEIN MEC 3; PROTEIN RNQ1; PROTEIN SUP35; PROTEIN URE2; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BETA SHEET; BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DISEASE TRANSMISSION; DOWN REGULATION; EPIGENETICS; FOOD CONTAMINATION; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPLICATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; INHERITANCE; MEMORY; MISSENSE MUTATION; MITOCHONDRIAL GENETICS; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVIEW; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE; SPECIES DIFFERENCE; STOP CODON; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; ULTRAVIOLET RADIATION; VIRUS GENE;

AMYLOID; ANIMALS; EVOLUTION; HUMANS; MEMORY; PRIONS; PROTEIN STRUCTURE, TERTIARY; SACCHAROMYCES CEREVISIAE PROTEINS;

BOVINAE; SACCHAROMYCES CEREVISIAE;

EID: 19544363062     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg1616     Document Type: Review

References (162)

1. James, L. C. & Tawfik, D. S. Conformational diversity and protein evolution - a 60-year-old hypothesis revisited. Trends Biochem. Sci. 28, 361-368 (2003).
2. Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144 (1982).
3. Wickner, R. B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566-569 (1994).
4. Si, K., Lindquist, S. & Kandel, E. R. A neuronal isoform of the Aplysia CPEB has prion-like properties. Cell 115, 879-891 (2003). This paper shows that ApCPEB can function as a prion in yeast, and that the prion conformation is the most active in stimulating translation of CPEB-regulated mRNA. Together with data from reference 99, the authors propose that the formation of ApCPEB prions in specifically stimulated synapses helps to maintain long-term synaptic changes that are associated with memory storage.
5. Prusiner, S. B. Prion Biology and Diseases (Cold Spring Harbor Laboratory Press, New York, 2004).
6. Uptain, S. M. & Lindquist, S. Prions as protein-based genetic elements. Annu. Rev. Microbiol. 56, 703-741 (2002).
7. Wickner, R. B., Liebman, S. W. & Saupe, S. J. in Prion Biology and Diseases (ed. Prusiner, S. B.) 305-372 (Cold Spring Harbor Laboratory Press New York, 2004).
8. Chien, P., Weissman, J. S. & DePace, A. H. Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem. 73, 617-656 (2004).
9. Alper, T., Cramp, W. A., Haig, D. A. & Clarke, M. C. Does the agent of scrapie replicate without nucleic acid? Nature 214, 764-766 (1967).
10. Griffith, J. S. Self-replication and scrapie. Nature 215, 1043-1044 (1967).
11. Prusiner, S. B. et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35, 349-358 (1983).
12. Kong, Q. et al. in Prion Biology and Diseases (ed. Prusiner, S. B.) 673-775 (Cold Spring Laboratory Press New York, 2004).
13. Bueler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347 (1993).
14. Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343 (1996).
15. Sc molecules with different conformations. Nature Med. 4, 1157-1165 (1998).
16. Cox, B. S. [PSI], a cytoplasmic suppressor of super-suppression in yeast. Heredity 20, 505-521 (1965).
17. Lacroute, F. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J. Bacteriol. 106, 519-522 (1971).
18. Sondheimer, N. & Lindquist, S. Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell 5, 163-172 (2000).
19. Santoso, A., Chien, P., Osherovich, L. Z. & Weissman, J. S. Molecular basis of a yeast prion species barrier. Cell 100, 277-288 (2000).
20. Osherovich, L. Z., Cox, B. S., Tuite, M. F. & Weissman, J. S. Dissection and design of yeast prions. PLoS Biol. 2, E86 (2004).
21. Coustou, V., Deleu, C., Saupe, S. & Begueret, J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl Acad. Sci. USA 94, 9773-9778 (1997).
22. Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B. & Cohen, F. E. Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem. 277, 21140-21148 (2002).
23. -], a heritable prion-like factor of S. cerevisiae. Cell 89, 811-819 (1997).
24. Taylor, K. L., Cheng, N., Williams, R. W., Steven, A. C. & Wickner, R. B. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283, 1339-1343 (1999).
25. Maddelein, M. L., Dos Reis, S., Duvezin-Caubet, S., Coulary-Salin, B. & Saupe, S. J. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl Acad. Sci. USA 99, 7402-7407 (2002).
26. Patino, M. M., Liu, J. J., Glover, J. R. & Lindquist, S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273, 622-626 (1996).
27. +) determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15, 3127-3134 (1996).
28. Masison, D. C. & Wickner, R. B. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270, 93-95 (1995).
29. Balguerie, A. et al. Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina. EMBO J. 22, 2071-2081 (2003).
30. Speransky, V. V., Taylor, K. L., Edskes, H. K., Wickner, R. B. & Steven, A. C. Prion filament networks in [URE3] cells of Saccharomyces cerevisiae. J. Cell Biol. 153, 1327-1336 (2001).
31. Kimura, Y., Koitabashi, S. & Fujita, T. Analysis of yeast prion aggregates with amyloid-staining compound in vivo. Cell Struct. Funct. 28, 187-193 (2003).
32. +] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J. Biol. Chem. 278, 49636-49643 (2003).
33. King, C. Y. & Diaz-Avalos, R. Protein-only transmission of three yeast prion strains. Nature 428, 319-323 (2004).
34. Serio, T. R. et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317-1321 (2000).
35. Dobson, C. M. Protein folding and misfolding. Nature 426, 884-890 (2003).
36. +] variants.
37. Legname, G. et al. Synthetic mammalian prions. Science 305, 673-676 (2004).
38. DePace, A. H. & Weissman, J. S. Origins and kinetic consequences of diversity in Sup35 yeast prion fibres. Nature Struct. Biol. 9, 389-396 (2002).
39. Baxa, U., Speransky, V., Steven, A. C. & Wickner, R. B. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein. Proc. Natl Acad. Sci. USA 99, 5253-5260 (2002).
40. Fink, G. R. A transforming principle. Cell 120, 153-154 (2005).
41. Kaneko, K. et al. A synthetic peptide initiates Gerstmann-Straussler- Scheinker (GSS) disease in transgenic mice. J. Mol. Biol. 295, 997-1007 (2000).
42. Legname, G. et al. Strain-specified characteristics of mouse synthetic prions. Proc. Natl Acad. Sci. USA 102, 2168-2173 (2005). References 37, 41 and 42 provide the initial foundations of definitive evidence for the mammalian prion hypothesis.
43. Edskes, H. K. & Wickner, R. B. Transmissible spongiform encephalopathies: prion proof in progress. Nature 430, 977-979 (2004).
44. Goudsmit, J. et al. Evidence for and against the transmissibility of Alzheimer disease. Neurology 30, 945-950 (1980).
45. West, M. W. et al. De novo amyloid proteins from designed combinatorial libraries. Proc. Natl Acad. Sci. USA 96, 11211-11216 (1999).
46. Medawar, P. B. An Unsolved Problem of Biology (H. K. Lewis, London, 1952).
47. Chernoff, Y. O. et al. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein. Mol. Microbiol. 35, 865-876 (2000).
48. +] 'prions' that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. Mol. Cell 7, 1121-1130 (2001).
49. Baudin-Baillieu, A., Fernandez-Bellot, E., Reine, F., Coissac, E. & Cullin, C. Conservation of the prion properties of Ure2p through evolution. Mol. Biol. Cell 14, 3449-3458 (2003).
50. Jensen, M. A., True, H. L., Chernoff, Y. O. & Lindquist, S. Molecular population genetics and evolution of a prion-like protein in Saccharomyces cerevisiae. Genetics 159, 527-535 (2001).
51. Lindquist, S. Mad cows meet psi-chotic yeast: the expansion of the prion hypothesis. Cell 89, 495-498 (1997).
52. Berson, J. F. et al. Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J. Cell Biol. 161, 521-533 (2003).
53. Mackay, J. P. et al. The hydrophobin EAS is largely unstructured in solution and functions by forming amyloid-like structures. Structure 9, 83-91 (2001).
54. Chapman, M. R. et al. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851-855 (2002).
55. Kranenburg, O. et al. Tissue-type plasminogen activator is a multiligand cross-β structure receptor. Curr. Biol. 12, 1833-1839 (2002). References 52-55 provide fascinating examples of beneficial amyloid conformers.
56. Gebbink, M. F., Voest, E. E. & Reijerkerk, A. Do antiangiogenic protein fragments have amyloid properties? Blood 104, 1601-1605 (2004).
57. Nucifora, F. C. Jr. et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291, 2423-2428 (2001).
58. Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (2003).
59. +]. Science 268, 880-884 (1995).
60. Moriyama, H., Edskes, H. K. & Wickner, R. B. [URE3] prion propagation in Saccharomyces cerevisiae: requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydj1p. Mol. Cell Biol. 20, 8916-8922 (2000).
61. +] prion. EMBO J. 20, 2435-2442 (2001).
62. +]. Mol. Biol. Cell. 14, 1172-1181 (2003).
63. Mallucci, G. et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874 (2003). This remarkable paper shows that prion diseases might be treated post infection by downregulating endogenous PrP.
64. Dorn, G. et al. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32, e49 (2004).
65. Xia, H. et al. RNAI suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nature Med. 10, 816-820 (2004).
66. Komar, A. A. et al. Internal initiation drives the synthesis of Ure2 protein lacking the prion domain and affects [URE3] propagation in yeast cells. EMBO J. 22, 1199-1209 (2003).
67. True, H. L. & Lindquist, S. L. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407, 477-483 (2000).
68. +] are distinguished by their efficiencies of prion-mediated conformational conversion. EMBO J. 20, 6236-8245 (2001).
69. Bidou, L. et al. Nonsense-mediated decay mutants do not affect programmed-1 frameshifting. RNA 6, 952-961 (2000).
70. Kellis, M., Patterson, N., Endrizzi, M., Birren, B. & Lander, E. S. Sequencing and comparison of yeast species to identify genes and regulatory elements. Nature 423, 241-254 (2003).
71. +] as a beneficial prion.
72. Eaglestone, S. S., Cox, B. S. & Tuite, M. F. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J. 18, 1974-1981 (1999).
73. Orr, H. A. The population genetics of adaptation: the distribution of factors fixed during adaptive evolution. Evolution 52, 935-949 (1998).
74. Partridge, L. & Barton, N. H. Evolving evolvability. Nature 407, 457-458 (2000).
75. Brookfield, J. F. Evolution: the evolvability enigma. Curr. Biol. 11, R106-R108 (2001).
76. Kirschner, M. & Gerhart, J. Evolvability. Proc. Natl Acad. Sci. USA 95, 8420-8427 (1998).
77. +] has probably been maintained owing to the evolvability properties that it confers.
78. Earl, D. J. & Deem, M. W. Evolvability is a selectable trait. Proc. Natl Acad. Sci. USA 101, 11531-11536 (2004).
79. Resende, C. G., Outeiro, T. F., Sands, L., Lindquist, S. & Tuite, M. F. Prion protein gene polymorphisms in Saccharomyces cerevisiae. Mol. Microbiol. 49, 1005-1017 (2003).
80. Lindquist, S. But yeast prion offers clues about evolution. Nature 408, 17-18 (2000).
81. Harrison, P. et al. A small reservoir of disabled ORFs in the yeast genome and its implications for the dynamics of proteome evolution. J. Mol. Biol. 316, 409-419 (2002).
82. Namy, O., Duchateau-Nguyen, G. & Rousset, J. P. Translational read through of the PDE2 stop codon modulates CAMP levels in Saccharomyces cerevisiae. Mol. Microbiol. 43, 641-652 (2002).
83. Dalstra, H. J., Swart, K., Debets, A. J., Saupe, S. J. & Hoekstra, R. F. Sexual transmission of the [Het-s] prion leads to meiotic drive in Podospora anserina. Proc. Natl Acad. Sci. USA 100, 6616-6621 (2003).
84. +l prion in Saccharomyces cerevisiae. Genetics 147, 507-519 (1997).
85. +]. Cell 106, 171-182 (2001).
86. Bradley, M. E., Edskes, H. K., Hong, J. Y., Wickner, R. B. & Liebman, S. W. Interactions among prions and prion 'strains' in yeast, Proc. Natl. Acad. Sci. USA 99 (Suppl. 4), 16392-16399 (2002).
87. Salmon, J. M. & Barre, P. Improvement of nitrogen assimilation and fermentation kinetics under enological conditions by derepression of alternative nitrogen-assimilatory pathways in an industrial Saccharomyces cerevisiae strain. Appl. Environ. Microbiol. 64, 3831-3837 (1998).
88. Crespo, J. L., Daicho, K., Ushimaru, T. & Hall, M. N. The GATA transcription factors GLN3 and GAT1 link TOR to salt stress in Saccharomyces cerevisiae J. Biol. Chem. 276, 34441-34444 (2001).
89. Bergman, A. & Siegal, M. L. Evolutionary capacitance as a general feature of complex gene networks. Nature 424, 549-552 (2003). This remarkable study indicates that many, if not all, genes expose phenotypic variation when functionally compromised, and that the availability of loss-of-function mutations expedites adaptation to new phenotypic optima. Therefore, evolutionary capacitors might be more widespread than previously anticipated.
90. Hughes, T. R. et al. Functional discovery via a compendium of expression profiles. Cell 102, 109-126 (2000).
91. Sangster, T. A., Lindquist, S. & Queitsch, C. Under cover: causes, effects and implications of Hsp90-mediated genetic capacitance. Bioessays 26, 348-362 (2004).
92. Michelitsch, M. D. & Weissman, J. S. A census of glutamine/ asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc. Natl Acad. Sci. USA 97, 11910-11915 (2000).
93. Harrison, P. M. & Gerstein, M. A method to assess compositional bias in biological sequences and its application to prion-like glutamine/asparagine- rich domains in eukaryotic proteomes. Genome Biol. 4, R40 (2003).
94. Flechsig, E. et al. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27, 399-408 (2000).
95. Liu, J. J. & Lindquist, S. Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast. Nature 400, 573-576 (1999).
96. Krishnan, R. & Lindquist, S. L. New structural insights on a yeast prion illuminate nucleation and strain diversity. Nature (in the press). This paper defines which regions of the Sup35 prion domain make intermolecular contacts in assembled prion fibres. It also describes how variations in these intermolecular contacts facilitate the construction of different prion variants.
97. Ross, E. D., Baxa, U. & Wickner, R. B. Scrambled prion domains form prions and amyloid. Mol. Cell Biol. 24, 7206-7213 (2004).
98. Uversky, V. N. & Fink, A. L. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta 1698, 131-153 (2004).
99. Si, K. et al. A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in Aplysia. Cell 115, 893-904 (2003). This paper establishes that neurotransmitter cues upregulate ApCPEB at specific synapses, and that consequent ApCPEB-stimulated translation has a crucial role in the maintenance of synaptic growth associated with long-term facilitation. Together with reference 4, this paper makes a compelling argument that ApCPEB prions function in long-term memory formation.
100. Bailey, C. H., Kandel, E. R. & Si, K. The persistence of long-term memory: a molecular approach to self-sustaining changes in learning-induced synaptic growth. Neuron 44, 49-57 (2004).
101. Lisman, J., Schulman, H. & Cline, H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nature Rev. Neurosci. 3, 175-190 (2002).
102. Bhalla, U. S. & Iyengar, R. Emergent properties of networks of biological signaling pathways. Science 283, 381-387 (1999).
103. Thayer, M. J. et al. Positive autoregulation of the myogenic determination gene MyoD1. Cell 58, 241-248 (1989).
104. Way, J. C. & Chalfie, M. The mec-3 gene of Caenorhabditis elegans requires its own product for maintained expression and is expressed in three neuronal cell types. Genes Dev. 3, 1823-1833 (1989).
105. Mendez, R. & Richter, J. D. Translational control by CPEB: a means to the end. Nature Rev. Mol. Cell Biol. 2, 521-529 (2001).
106. Uversky, V. N., Gillespie, J. R. & Fink, A. L. Why are 'natively unfolded' proteins unstructured under physiologic conditions? Proteins 41, 415-427 (2000).
107. Sajikumar, S. & Frey, J. U. Late-associativity, synaptic tagging, and the role of dopamine during LTP and LTD. Neurobiol. Learn. Mem. 82, 12-25 (2004).
108. Theis, M., Si, K. & Kandel, E. R. Two previously undescribed members of the mouse CPEB family of genes and their inducible expression in the principal cell layers of the hippocampus. Proc. Natl Acad. Sci. USA 100, 9602-9607 (2003).
109. Li, L. & Lindquist, S. Creating a protein-based element of inheritance. Science 287, 661-664 (2000).
110. Ter-Avanesyan, M. D. et al. Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol. Microbiol. 7, 683-692 (1993).
111. Ringrose, L. & Para, R. Epigenetic regulation of cellular memory by the polycomb and trithorax group proteins. Annu. Rev. Genet. 38, 413-443 (2004).
112. Kim, C. A., Gingery, M., Pilpa, R. M. & Bowie, J. U. The SAM domain of polyhomeotic forms a helical polymer. Nature Struct. Biol. 9, 453-457 (2002).
113. Qiao, F. et al. Derepression by depolymerization; structural insights into the regulation of Yan by Mae. Cell 118, 163-173 (2004).
114. Roberts, C. W. & Orkin, S. H. The SWI/SNF complex - chromatin and cancer. Nature Rev. Cancer 4, 133-142 (2004).
115. Sudarsanam, P., Iyer, V. R., Brown, P. O. & Winston, F. Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 97, 3364-3369 (2000).
116. Gilks, N. et al. Stress granule assembly is mediated by prion-like aggregation of TIA-1. Mol. Biol. Cell 15, 5383-5398 (2004).
117. Roberts, B. T. & Wickner, R. B. Heritable activity: a prion that propagates by covalent autoactivation. Genes Dev. 17, 2083-2087 (2003).
118. Collin, P., Beauregard, P. B., Elagoz, A. & Rokeach, L. A. A non-chromosomal factor allows viability of Schizosaccharomyces pombe lacking the essential chaperone calnexin. J. Cell Sci. 117, 907-918 (2004).
119. Ball, A. J., Wong, D. K. & Elliott, J. J. Glucosamine resistance in yeast. I. A preliminary genetic analysis. Genetics 84, 311-317 (1976).
120. Silar, P., Haedens, V., Rossignol, M. & Lalucque, H. Propagation of a novel cytoplasmic, infectious and deleterious determinant is controlled by translational accuracy in Podospora anserina. Genetics 151, 87-95 (1999).
121. Talloczy, Z., Menon, S., Neigeborn, L. & Leibowitz, M. J. The [KIL-d] cytoplasmic genetic element of yeast results in epigenetic regulation of viral M double-stranded RNA gene expression. Genetics 150, 21-30 (1998).
122. Volkov, K. V. et al. Novel non-Mendelian determinant involved in the control of translation accuracy in Saccharomyces cerevisiae. Genetics 160, 25-36 (2002).
123. Derkatch, I. L., Chernoff, Y. O., Kushnirov, V. V., Inge-Vechtomov, S. G. & Liebman, S. W. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 144, 1375-1386 (1996).
124. +] in the yeast Saccharomyces cerevisiae. Genetics 137, 671-676 (1994).
125. +]. Proc. Natl Acad. Sci. USA 99 (Suppl. 4), 16446-16453 (2002).
126. +] form separate structures in yeast. J. Biol. Chem. 279, 51042-51048 (2004).
127. Schlumpberger, M., Prusiner, S. B. & Herskowitz, I. Induction of distinct [URE3] yeast prion strains. Mol. Cell. Biol. 21, 7035-7046 (2001).
128. +] prion. Cell 106, 183-194 (2001).
129. +] prion in yeast and aggregation of Sup35 in vitro. Proc. Natl Acad. Sci. USA 101, 12934-12939 (2004).
130. +]: a two-prion system in yeast? EMBO J. 19, 1942-1952 (2000).
131. +] yeast prion variants. Genetics 165, 1675-1685 (2003).
132. Baker, H. F., Ridley, R. M., Duchen, L. W., Crow, T. J. & Bruton, C. J. Induction of β(A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol. Neurobiol. 8, 25-39 (1994).
133. Lundmark, K. et al. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl Acad. Sci. USA 99, 6979-6984 (2002).
134. Xing, Y. et al. Induction of protein conformational change in mouse senile amyloidosis. J. Biol. Chem. 277, 33164-33169 (2002).
135. Prinz, M. et al. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425, 957-962 (2003).
136. Tanaka, M., Chien, P., Yonekura, K. & Weissman, J. S. Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins. Cell 121, 49-62 (2005).
137. Shorter, J. & Lindquist, S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304, 1793-1797 (2004). A delineation of how Hsp104 directly regulates Sup35 prion conformers.
138. Scheibel, T. et al. Conducting nanowires built by controlled self-assembly of amyloid fibres and selective metal deposition. Proc. Natl Acad. Sci. USA 100, 4527-4532 (2003).
139. Masel, J., Jansen, V. A. & Nowak, M. A. Quantifying the kinetic parameters of prion replication. Biophys. Chem. 77, 139-152 (1999).
140. Lee, D. H., Granja, J. R., Martinez, J. A., Severin, K. & Ghadiri, M. R. A self-replicating peptide. Nature 382, 525-528 (1996).
141. Lee, D. H., Severin, K., Yokobayashi, Y. & Ghadiri, M. R. Emergence of symbiosis in peptide self-replication through a hypercyclic network. Nature 390, 591-594 (1997).
142. Saghatelian, A., Yokobayashi, Y., Soltani, K. & Ghadiri, M. R. A chiroselective peptide replicator. Nature 409, 797-801 (2001). References 140-142 describe a remarkable set of short α-helical peptides that can undergo chemical and conformational replication, and which might even help to explain the origins of homochirality.
143. Pan, K. M. et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl Acad. Sci. USA 90, 10962-10966 (1993).
144. Wille, H., Zhang, G. F., Baldwin, M. A., Cohen, F. E. & Prusiner, S. B. Separation of scrapie prion infectivity from PrP amyloid polymers. J. Mol. Biol. 259, 608-621 (1996).
145. Parsell, D. A., Kowal, A. S., Singer, M. A., & Lindquist, S. Protein disaggregation mediated by heat-shock protein Hsp104. Nature 372, 475-478 (1994).
146. Glover, J. R. & Lindquist, S. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94, 73-82 (1998).
147. Wegrzyn, R. D., Bapat, K., Newnam, G. P., Zink, A. D. & Chernoff, Y. O. Mechanism of prion loss after Hsp104 inactivation in yeast. Mol. Cell Biol. 21, 4656-4669 (2001).
148. Hattendorf, D. A. & Lindquist, S. L. Analysis of the AAA sensor-2 motif in the C-terminal ATPase domain of Hsp104 with a site-specific fluorescent probe of nucleotide binding. Proc. Natl Acad. Sci. USA 99, 2732-2737 (2002).
149. Hattendorf, D. A. & Lindquist, S. L. Cooperative kinetics of both Hsp104 ATPase domains and interdomain communication revealed by AAA sensor-1 mutants. EMBO J. 21, 12-21 (2002).
150. Grimminger, V., Richter, K., Imhof, A., Buchner, J. & Walter, S. The prion curing agent guanidinium chloride specifically inhibits ATP hydrolysis by Hsp104. J. Biol. Chem. 279, 7378-7383 (2004).
151. Ripaud, L., Maillet, L. & Cullin, C. The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products. EMBO J. 22, 5251-5259 (2003).
152. Collins, S. R., Douglass, A., Vale, R. D. & Welssman, J. S. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol. 2, e321 (2004).
153. Inoue, Y., Taguchi, H., Kishimoto, A. & Yoshida, M. Hsp104 binds to yeast Sup35 prion fibre but needs other factor(s) to sever it. J. Biol. Chem. 279, 52319-52323 (2004).
154. +] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol. Microbiol. 40, 1357-1369 (2001).
155. Shorter, J. & Lindquist, S. Navigating the ClpB channel to solution. Nature Struct. Mol. Biol. 12, 4-6 (2005).
156. +]-ched about. Trends Cell Biol. 10, 98-105 (2000).
157. Leeds, P., Peltz, S. W., Jacobson, A. & Culbertson, M. R. The product of the yeast UPF1 gene is required for rapid turnover of mRNAs containing a premature translational termination codon. Genes Dev. 5, 2303-2314 (1991).
158. Frischmeyer, P. A. et al. An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science 295, 2258-2261 (2002).
159. Bence, N. F., Sampat, R. M. & Kopito, R. R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-155 (2001).
160. Venkatraman, P., Wetzel, R., Tanaka, M., Nukina, N. & Goldberg, A. L. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol. Cell 14, 95-104 (2004).
161. Castilla, J., Saa, P., Hetz, C. & Soto, C. In vitro generation of infectious scrapie prions. Cell 121, 195-206 (2005).
162. Zou, W. Q. & Gambetti, P. From microbes to prions the final proof of the prion hypothesis. Cell 121, 155-157 (2005).